-
A cohomology-based Gromov-Hausdorff metric approach for quantifying molecular similarity
Authors:
JunJie Wee,
Xue Gong,
Wilderich Tuschmann,
Kelin Xia
Abstract:
We introduce, for the first time, a cohomology-based Gromov-Hausdorff ultrametric method to analyze 1-dimensional and higher-dimensional (co)homology groups, focusing on loops, voids, and higher-dimensional cavity structures in simplicial complexes, to address typical clustering questions arising in molecular data analysis. The Gromov-Hausdorff distance quantifies the dissimilarity between two met…
▽ More
We introduce, for the first time, a cohomology-based Gromov-Hausdorff ultrametric method to analyze 1-dimensional and higher-dimensional (co)homology groups, focusing on loops, voids, and higher-dimensional cavity structures in simplicial complexes, to address typical clustering questions arising in molecular data analysis. The Gromov-Hausdorff distance quantifies the dissimilarity between two metric spaces. In this framework, molecules are represented as simplicial complexes, and their cohomology vector spaces are computed to capture intrinsic topological invariants encoding loop and cavity structures. These vector spaces are equipped with a suitable distance measure, enabling the computation of the Gromov-Hausdorff ultrametric to evaluate structural dissimilarities. We demonstrate the methodology using organic-inorganic halide perovskite (OIHP) structures. The results highlight the effectiveness of this approach in clustering various molecular structures. By incorporating geometric information, our method provides deeper insights compared to traditional persistent homology techniques.
△ Less
Submitted 25 February, 2025; v1 submitted 21 November, 2024;
originally announced November 2024.
-
Topology-enhanced machine learning model (Top-ML) for anticancer peptide prediction
Authors:
Joshua Zhi En Tan,
JunJie Wee,
Xue Gong,
Kelin Xia
Abstract:
Recently, therapeutic peptides have demonstrated great promise for cancer treatment. To explore powerful anticancer peptides, artificial intelligence (AI)-based approaches have been developed to systematically screen potential candidates. However, the lack of efficient featurization of peptides has become a bottleneck for these machine-learning models. In this paper, we propose a topology-enhanced…
▽ More
Recently, therapeutic peptides have demonstrated great promise for cancer treatment. To explore powerful anticancer peptides, artificial intelligence (AI)-based approaches have been developed to systematically screen potential candidates. However, the lack of efficient featurization of peptides has become a bottleneck for these machine-learning models. In this paper, we propose a topology-enhanced machine learning model (Top-ML) for anticancer peptides prediction. Our Top-ML employs peptide topological features derived from its sequence "connection" information characterized by vector and spectral descriptors. Our Top-ML model, employing an Extra-Trees classifier, has been validated on the AntiCP 2.0 and mACPpred 2.0 benchmark datasets, achieving state-of-the-art performance or results comparable to existing deep learning models, while providing greater interpretability. Our results highlight the potential of leveraging novel topology-based featurization to accelerate the identification of anticancer peptides.
△ Less
Submitted 15 April, 2025; v1 submitted 12 July, 2024;
originally announced July 2024.
-
Benchmarking AlphaFold3's protein-protein complex accuracy and machine learning prediction reliability for binding free energy changes upon mutation
Authors:
JunJie Wee,
Guo-Wei Wei
Abstract:
AlphaFold 3 (AF3), the latest version of protein structure prediction software, goes beyond its predecessors by predicting protein-protein complexes. It could revolutionize drug discovery and protein engineering, marking a major step towards comprehensive, automated protein structure prediction. However, independent validation of AF3's predictions is necessary. Evaluated using the SKEMPI 2.0 datab…
▽ More
AlphaFold 3 (AF3), the latest version of protein structure prediction software, goes beyond its predecessors by predicting protein-protein complexes. It could revolutionize drug discovery and protein engineering, marking a major step towards comprehensive, automated protein structure prediction. However, independent validation of AF3's predictions is necessary. Evaluated using the SKEMPI 2.0 database which involves 317 protein-protein complexes and 8338 mutations, AF3 complex structures give rise to a very good Pearson correlation coefficient of 0.86 for predicting protein-protein binding free energy changes upon mutation, slightly less than the 0.88 achieved earlier with the Protein Data Bank (PDB) structures. Nonetheless, AF3 complex structures led to a 8.6% increase in the prediction RMSE compared to original PDB complex structures. Additionally, some of AF3's complex structures have large errors, which were not captured in its ipTM performance metric. Finally, it is found that AF3's complex structures are not reliable for intrinsically flexible regions or domains.
△ Less
Submitted 6 June, 2024;
originally announced June 2024.
-
Integration of persistent Laplacian and pre-trained transformer for protein solubility changes upon mutation
Authors:
JunJie Wee,
Jiahui Chen,
Kelin Xia,
Guo-Wei Wei
Abstract:
Protein mutations can significantly influence protein solubility, which results in altered protein functions and leads to various diseases. Despite of tremendous effort, machine learning prediction of protein solubility changes upon mutation remains a challenging task as indicated by the poor scores of normalized Correct Prediction Ratio (CPR). Part of the challenge stems from the fact that there…
▽ More
Protein mutations can significantly influence protein solubility, which results in altered protein functions and leads to various diseases. Despite of tremendous effort, machine learning prediction of protein solubility changes upon mutation remains a challenging task as indicated by the poor scores of normalized Correct Prediction Ratio (CPR). Part of the challenge stems from the fact that there is no three-dimensional (3D) structures for the wild-type and mutant proteins. This work integrates persistent Laplacians and pre-trained Transformer for the task. The Transformer, pretrained with hunderds of millions of protein sequences, embeds wild-type and mutant sequences, while persistent Laplacians track the topological invariant change and homotopic shape evolution induced by mutations in 3D protein structures, which are rendered from AlphaFold2. The resulting machine learning model was trained on an extensive data set labeled with three solubility types. Our model outperforms all existing predictive methods and improves the state-of-the-art up to 15%.
△ Less
Submitted 2 November, 2023; v1 submitted 28 October, 2023;
originally announced October 2023.
